在智力障碍患者中降低处方
Larrilyn Grant1, Kari Harper1, Julie P Gentile1
1All authors are with the Department of Psychiatry at Wright State University in Dayton, Ohio.
Innovations in clinical neuroscience
|August 11, 2025
概括
智力障碍 (ID) 患者患精神疾病和多药性疾病的比率更高. 适应心理治疗和抑郁治疗方案可以改善这些患者的生活质量.
科学领域:
- 精神病学是一个精神病学.
- 智力障碍研究 智力障碍研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 精神疾病在智力障碍 (ID) 患者中比一般人群更为普遍.
- 患有智障的个体通常具有有限的应对机制和支持系统,增加了对压力的脆弱性.
- 多药在患有同时出现的ID和精神疾病的患者中很常见,在机构出院后经常继续.
研究的目的:
- 对智力障碍患者适应心理治疗的应用进行审查.
- 讨论在这个人群中管理多种药物的脱处方协议.
- 突出提高ID和精神疾病患者生活质量的策略.
主要方法:
- 对适应心理治疗技术的审查,适用于ID的个体.
- 检查放弃处方协议及其在减少多种药物的有效性.
- 分析说明诊断和治疗方法的案例研究.
主要成果:
- 适应性心理治疗对ID患者可能是有效的.
- 停止处方协议提供了一种结构化的方法来减少不必要的药物.
- 综合精神和身体健康管理对这一群体至关重要.
结论:
- 适应智力障碍的心理治疗可以提高心理健康结果.
- 为管理多药店和提高患者安全,有系统的减记是必不可少的.
- 需要全面的护理策略来改善ID和同时出现的精神疾病的个体的生活质量.
相关概念视频
01:29Intellectual Disability
159
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
159
01:26Psychosis: Goals of Pharmacotherapy
209
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
209
01:28Drug Therapy
98
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
98
01:21Factors Affecting Drug Response: Overview
2.4K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K
01:25Antidepressant Drugs: Overview
755
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
755
01:23Antidepressant Drugs: MAOIs and Other Agents
349
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
349